University of Utah Health Sciences June 9, 2021
The University of Utah today announced a landmark gift of $110 million for its School of Medicine from the George S. and Dolores Doré Eccles Foundation and the Nora Eccles Treadwell Foundation.
The gift will further accelerate the nationally recognized school’s ability to provide the highest quality medical education, advanced research, and patient care, dramatically increasing the school’s endowment and powering critical research. It will also enable the construction of a state-of-the-art new home for the School of Medicine on the health sciences campus.
President Emerita Ruth V. Watkins, Ph.D., and Interim President Michael Good, M.D., announced that the university will rename the school the Spencer Fox Eccles School of Medicine at the University of Utah. The naming acknowledges not only this gift, but the lifetime of leadership, vision, and advocacy of Mr. Eccles, chairman and CEO of the two foundations awa
E-Mail
Hypertrophic cardiomyopathy (HCM) is a cardiovascular disease characterized by thickening of the left ventricle, otherwise known as the main squeezing chamber of the heart. HCM is best known for causing sudden death in athletes but can occur in persons of any age, often without symptoms. While frequently discussed in the context of genetics, most patients with HCM do not have a known genetic variant. Investigators from Brigham and Women s Hospital uncovered a means to study the complexity of this disease beyond the identification of individual genes. This new approach offers a path toward treating HCM using individualized medicine. In a recent study, investigators analyzed the role protein-protein interactions (PPIs) play in differentiating individual cases of HCM. Their results are published in